Physician profile
Swetha Nataraj
NPI 1336348978
$72,131.03
in general payments reported to CMS, 2019-2025
9 companies · $6,306 in 2025
The $6,306 reported for 2025 was more than what 94% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $6,910 · 2021: $6,186 · 2022: $9,908 · 2023: $1.31 · 2024: $12K · 2025: $6,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $592 · Travel and Lodging: $505 · Education: $27.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,990.00 |
| Food and Beverage | $592.29 |
| Travel and Lodging | $505.24 |
| Education | $27.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $29,967.17 | 2019-2022 | |
| Vifor Pharma, INC. | $23,948.75 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,965.85 | 2024-2025 | Jardiance |
| Lilly USA, LLC | $8,057.00 | 2024-2025 | Jardiance |
| Baxter Healthcare | $122.08 | 2022-2024 | Renal - Chronic |
| Akebia Therapeutics INC | $24.61 | 2024 | Vafseo |
| Novo Nordisk INC | $21.44 | 2025 | Wegovy |
| Scpharmaceuticals INC. | $21.16 | 2025 | |
| Travere Therapeutics, INC. | $2.97 | 2023-2025 | Filspari |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swetha Nataraj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.